Electric Therapy Traction Table Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
The global Blood Cancer Detection market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Serve Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Blood Cancer Detection include Abbott Laboratories, F.Hoffman-LaRoche, QIAGEN, Thermo Fisher Scientific, lllumina, Bio-Rad Laboratories, MolecularMD, ArcherDX and ARUP Laboratories, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
Diagnosis of hematological tumors is the analysis and diagnosis of tumors using blood
This report aims to provide a comprehensive presentation of the global market for Blood Cancer Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Blood Cancer Detection. This report contains market size and forecasts of Blood Cancer Detection in global, including the following market information:
Global Blood Cancer Detection Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Blood Cancer Detection Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Blood Cancer Detection companies in 2022 (%)
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Blood Cancer Detection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Blood Cancer Detection Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Cancer Detection Market Segment Percentages, by Type, 2022 (%)
Serve
Detection Kit
Global Blood Cancer Detection Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Cancer Detection Market Segment Percentages, by Application, 2022 (%)
Clinical Laboratory
Hospital
Academic Research Institution
Other
Global Blood Cancer Detection Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Blood Cancer Detection Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Blood Cancer Detection revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Blood Cancer Detection revenues share in global market, 2022 (%)
Key companies Blood Cancer Detection sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Blood Cancer Detection sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
F.Hoffman-LaRoche
QIAGEN
Thermo Fisher Scientific
lllumina
Bio-Rad Laboratories
MolecularMD
ArcherDX
ARUP Laboratories
Asuragen
Invivoscribe
Adaptive
Biotechnologies
Amoy Diagnostics
ELITechGroup
VelaDiagnostics
Gentronix
BiolVT
SAGA Diagnostics
Olink
Cancer Diagnostics
Outline of Major Chapters:
Chapter 1: Introduces the definition of Blood Cancer Detection, market overview.
Chapter 2: Global Blood Cancer Detection market size in revenue and volume.
Chapter 3: Detailed analysis of Blood Cancer Detection manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Blood Cancer Detection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Blood Cancer Detection capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
1 Introduction to Research & Analysis Reports
1.1 Blood Cancer Detection Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Blood Cancer Detection Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Blood Cancer Detection Overall Market Size
2.1 Global Blood Cancer Detection Market Size: 2022 VS 2029
2.2 Global Blood Cancer Detection Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Blood Cancer Detection Sales: 2018-2029
3 Company Landscape
3.1 Top Blood Cancer Detection Players in Global Market
3.2 Top Global Blood Cancer Detection Companies Ranked by Revenue
3.3 Global Blood Cancer Detection Revenue by Companies
3.4 Global Blood Cancer Detection Sales by Companies
3.5 Global Blood Cancer Detection Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Blood Cancer Detection Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Blood Cancer Detection Product Type
3.8 Tier 1, Tier 2 and Tier 3 Blood Cancer Detection Players in Global Market
3.8.1 List of Global Tier 1 Blood Cancer Detection Companies
3.8.2 List of Global Tier 2 and Tier 3 Blood Cancer Detection Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Blood Cancer Detection Market Size Markets, 2022 & 2029
4.1.2 Serve
4.1.3 Detection Kit
4.2 By Type - Global Blood Cancer Detection Revenue & Forecasts
4.2.1 By Type - Global Blood Cancer Detection Revenue, 2018-2023
4.2.2 By Type - Global Blood Cancer Detection Revenue, 2024-2029
4.2.3 By Type - Global Blood Cancer Detection Revenue Market Share, 2018-2029
4.3 By Type - Global Blood Cancer Detection Sales & Forecasts
4.3.1 By Type - Global Blood Cancer Detection Sales, 2018-2023
4.3.2 By Type - Global Blood Cancer Detection Sales, 2024-2029
4.3.3 By Type - Global Blood Cancer Detection Sales Market Share, 2018-2029
4.4 By Type - Global Blood Cancer Detection Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Blood Cancer Detection Market Size, 2022 & 2029
5.1.2 Clinical Laboratory
5.1.3 Hospital
5.1.4 Academic Research Institution
5.1.5 Other
5.2 By Application - Global Blood Cancer Detection Revenue & Forecasts
5.2.1 By Application - Global Blood Cancer Detection Revenue, 2018-2023
5.2.2 By Application - Global Blood Cancer Detection Revenue, 2024-2029
5.2.3 By Application - Global Blood Cancer Detection Revenue Market Share, 2018-2029
5.3 By Application - Global Blood Cancer Detection Sales & Forecasts
5.3.1 By Application - Global Blood Cancer Detection Sales, 2018-2023
5.3.2 By Application - Global Blood Cancer Detection Sales, 2024-2029
5.3.3 By Application - Global Blood Cancer Detection Sales Market Share, 2018-2029
5.4 By Application - Global Blood Cancer Detection Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region - Global Blood Cancer Detection Market Size, 2022 & 2029
6.2 By Region - Global Blood Cancer Detection Revenue & Forecasts
6.2.1 By Region - Global Blood Cancer Detection Revenue, 2018-2023
6.2.2 By Region - Global Blood Cancer Detection Revenue, 2024-2029
6.2.3 By Region - Global Blood Cancer Detection Revenue Market Share, 2018-2029
6.3 By Region - Global Blood Cancer Detection Sales & Forecasts
6.3.1 By Region - Global Blood Cancer Detection Sales, 2018-2023
6.3.2 By Region - Global Blood Cancer Detection Sales, 2024-2029
6.3.3 By Region - Global Blood Cancer Detection Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country - North America Blood Cancer Detection Revenue, 2018-2029
6.4.2 By Country - North America Blood Cancer Detection Sales, 2018-2029
6.4.3 US Blood Cancer Detection Market Size, 2018-2029
6.4.4 Canada Blood Cancer Detection Market Size, 2018-2029
6.4.5 Mexico Blood Cancer Detection Market Size, 2018-2029
6.5 Europe
6.5.1 By Country - Europe Blood Cancer Detection Revenue, 2018-2029
6.5.2 By Country - Europe Blood Cancer Detection Sales, 2018-2029
6.5.3 Germany Blood Cancer Detection Market Size, 2018-2029
6.5.4 France Blood Cancer Detection Market Size, 2018-2029
6.5.5 U.K. Blood Cancer Detection Market Size, 2018-2029
6.5.6 Italy Blood Cancer Detection Market Size, 2018-2029
6.5.7 Russia Blood Cancer Detection Market Size, 2018-2029
6.5.8 Nordic Countries Blood Cancer Detection Market Size, 2018-2029
6.5.9 Benelux Blood Cancer Detection Market Size, 2018-2029
6.6 Asia
6.6.1 By Region - Asia Blood Cancer Detection Revenue, 2018-2029
6.6.2 By Region - Asia Blood Cancer Detection Sales, 2018-2029
6.6.3 China Blood Cancer Detection Market Size, 2018-2029
6.6.4 Japan Blood Cancer Detection Market Size, 2018-2029
6.6.5 South Korea Blood Cancer Detection Market Size, 2018-2029
6.6.6 Southeast Asia Blood Cancer Detection Market Size, 2018-2029
6.6.7 India Blood Cancer Detection Market Size, 2018-2029
6.7 South America
6.7.1 By Country - South America Blood Cancer Detection Revenue, 2018-2029
6.7.2 By Country - South America Blood Cancer Detection Sales, 2018-2029
6.7.3 Brazil Blood Cancer Detection Market Size, 2018-2029
6.7.4 Argentina Blood Cancer Detection Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Blood Cancer Detection Revenue, 2018-2029
6.8.2 By Country - Middle East & Africa Blood Cancer Detection Sales, 2018-2029
6.8.3 Turkey Blood Cancer Detection Market Size, 2018-2029
6.8.4 Israel Blood Cancer Detection Market Size, 2018-2029
6.8.5 Saudi Arabia Blood Cancer Detection Market Size, 2018-2029
6.8.6 UAE Blood Cancer Detection Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Abbott Laboratories
7.1.1 Abbott Laboratories Company Summary
7.1.2 Abbott Laboratories Business Overview
7.1.3 Abbott Laboratories Blood Cancer Detection Major Product Offerings
7.1.4 Abbott Laboratories Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.1.5 Abbott Laboratories Key News & Latest Developments
7.2 F.Hoffman-LaRoche
7.2.1 F.Hoffman-LaRoche Company Summary
7.2.2 F.Hoffman-LaRoche Business Overview
7.2.3 F.Hoffman-LaRoche Blood Cancer Detection Major Product Offerings
7.2.4 F.Hoffman-LaRoche Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.2.5 F.Hoffman-LaRoche Key News & Latest Developments
7.3 QIAGEN
7.3.1 QIAGEN Company Summary
7.3.2 QIAGEN Business Overview
7.3.3 QIAGEN Blood Cancer Detection Major Product Offerings
7.3.4 QIAGEN Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.3.5 QIAGEN Key News & Latest Developments
7.4 Thermo Fisher Scientific
7.4.1 Thermo Fisher Scientific Company Summary
7.4.2 Thermo Fisher Scientific Business Overview
7.4.3 Thermo Fisher Scientific Blood Cancer Detection Major Product Offerings
7.4.4 Thermo Fisher Scientific Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.4.5 Thermo Fisher Scientific Key News & Latest Developments
7.5 lllumina
7.5.1 lllumina Company Summary
7.5.2 lllumina Business Overview
7.5.3 lllumina Blood Cancer Detection Major Product Offerings
7.5.4 lllumina Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.5.5 lllumina Key News & Latest Developments
7.6 Bio-Rad Laboratories
7.6.1 Bio-Rad Laboratories Company Summary
7.6.2 Bio-Rad Laboratories Business Overview
7.6.3 Bio-Rad Laboratories Blood Cancer Detection Major Product Offerings
7.6.4 Bio-Rad Laboratories Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.6.5 Bio-Rad Laboratories Key News & Latest Developments
7.7 MolecularMD
7.7.1 MolecularMD Company Summary
7.7.2 MolecularMD Business Overview
7.7.3 MolecularMD Blood Cancer Detection Major Product Offerings
7.7.4 MolecularMD Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.7.5 MolecularMD Key News & Latest Developments
7.8 ArcherDX
7.8.1 ArcherDX Company Summary
7.8.2 ArcherDX Business Overview
7.8.3 ArcherDX Blood Cancer Detection Major Product Offerings
7.8.4 ArcherDX Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.8.5 ArcherDX Key News & Latest Developments
7.9 ARUP Laboratories
7.9.1 ARUP Laboratories Company Summary
7.9.2 ARUP Laboratories Business Overview
7.9.3 ARUP Laboratories Blood Cancer Detection Major Product Offerings
7.9.4 ARUP Laboratories Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.9.5 ARUP Laboratories Key News & Latest Developments
7.10 Asuragen
7.10.1 Asuragen Company Summary
7.10.2 Asuragen Business Overview
7.10.3 Asuragen Blood Cancer Detection Major Product Offerings
7.10.4 Asuragen Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.10.5 Asuragen Key News & Latest Developments
7.11 Invivoscribe
7.11.1 Invivoscribe Company Summary
7.11.2 Invivoscribe Blood Cancer Detection Business Overview
7.11.3 Invivoscribe Blood Cancer Detection Major Product Offerings
7.11.4 Invivoscribe Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.11.5 Invivoscribe Key News & Latest Developments
7.12 Adaptive
Biotechnologies
7.12.1 Adaptive
Biotechnologies Company Summary
7.12.2 Adaptive
Biotechnologies Blood Cancer Detection Business Overview
7.12.3 Adaptive
Biotechnologies Blood Cancer Detection Major Product Offerings
7.12.4 Adaptive
Biotechnologies Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.12.5 Adaptive
Biotechnologies Key News & Latest Developments
7.13 Amoy Diagnostics
7.13.1 Amoy Diagnostics Company Summary
7.13.2 Amoy Diagnostics Blood Cancer Detection Business Overview
7.13.3 Amoy Diagnostics Blood Cancer Detection Major Product Offerings
7.13.4 Amoy Diagnostics Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.13.5 Amoy Diagnostics Key News & Latest Developments
7.14 ELITechGroup
7.14.1 ELITechGroup Company Summary
7.14.2 ELITechGroup Business Overview
7.14.3 ELITechGroup Blood Cancer Detection Major Product Offerings
7.14.4 ELITechGroup Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.14.5 ELITechGroup Key News & Latest Developments
7.15 VelaDiagnostics
7.15.1 VelaDiagnostics Company Summary
7.15.2 VelaDiagnostics Business Overview
7.15.3 VelaDiagnostics Blood Cancer Detection Major Product Offerings
7.15.4 VelaDiagnostics Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.15.5 VelaDiagnostics Key News & Latest Developments
7.16 Gentronix
7.16.1 Gentronix Company Summary
7.16.2 Gentronix Business Overview
7.16.3 Gentronix Blood Cancer Detection Major Product Offerings
7.16.4 Gentronix Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.16.5 Gentronix Key News & Latest Developments
7.17 BiolVT
7.17.1 BiolVT Company Summary
7.17.2 BiolVT Business Overview
7.17.3 BiolVT Blood Cancer Detection Major Product Offerings
7.17.4 BiolVT Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.17.5 BiolVT Key News & Latest Developments
7.18 SAGA Diagnostics
7.18.1 SAGA Diagnostics Company Summary
7.18.2 SAGA Diagnostics Business Overview
7.18.3 SAGA Diagnostics Blood Cancer Detection Major Product Offerings
7.18.4 SAGA Diagnostics Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.18.5 SAGA Diagnostics Key News & Latest Developments
7.19 Olink
7.19.1 Olink Company Summary
7.19.2 Olink Business Overview
7.19.3 Olink Blood Cancer Detection Major Product Offerings
7.19.4 Olink Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.19.5 Olink Key News & Latest Developments
7.20 Cancer Diagnostics
7.20.1 Cancer Diagnostics Company Summary
7.20.2 Cancer Diagnostics Business Overview
7.20.3 Cancer Diagnostics Blood Cancer Detection Major Product Offerings
7.20.4 Cancer Diagnostics Blood Cancer Detection Sales and Revenue in Global (2018-2023)
7.20.5 Cancer Diagnostics Key News & Latest Developments
8 Global Blood Cancer Detection Production Capacity, Analysis
8.1 Global Blood Cancer Detection Production Capacity, 2018-2029
8.2 Blood Cancer Detection Production Capacity of Key Manufacturers in Global Market
8.3 Global Blood Cancer Detection Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Blood Cancer Detection Supply Chain Analysis
10.1 Blood Cancer Detection Industry Value Chain
10.2 Blood Cancer Detection Upstream Market
10.3 Blood Cancer Detection Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Blood Cancer Detection Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LED Light-Up Blanket Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 116 |
Pelvic Floor Functional Magnetic Stimulator Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Multi-Modality Biofeedback System Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 112 |
High Frequency Evaluation and Therapy Device Market, Global Outlook and Forecast 2023-2029
| Price : US $3250 | Date : May 2023 |
| CAT ID : 7 | Pages : 115 |
Choose License Type
Why Choose Us ?
24/7 Research support
Quality assurance
Information security
The report efficiently evaluates the market from various dimensions to deliver an
end-product that is informative, elaborate, and accurate and includes detailed
market segmentation, regional analysis, and competitive landscape of the industry.
The report efficiently evaluates the current market size and provides industry forecast.
The market was valued at xx Million US$ in 2019, and is expected to grow at a CAGR of
xx% during the period 2020-2027.
The report efficiently evaluates the current market size and provides forecast for the
industry in terms of Value (US$ Mn) and Volume (Thousands Units).
Market is segmented by Types, Applications, Technology, End-use Industries, and Regions.
The report presents the current market size, and market forecast, market
opportunities, key drivers and restraints, regulatory scenario, industry trend, PESTLE
analysis, PORTER’s analysis, new product approvals/launch, promotion and marketing
initiatives, pricing analysis, competitive landscape which help businesses in
decision making. The analysis data is based on current and historical market trends
which help in investment related decisions.
Custom research is crucial components of the business strategy which helps any
organization to gain insight into specific business sector, aligned with specific area
of interest. Thus, SMI offers more accurate, pragmatic, and actionable information
specifically tailored to suit your business needs.
